The agency affirmed the use of biopsies for biomarker-driven trials but cautioned against optional biopsies that offer little value to the patient or trial.
The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.
A new blood test to detect cancer at an early stage has shown promising results, according to a study, as scientists aim to ...
GEN invited a group of multiomics experts to share their predictions of the potential and needs of multiomics in the near ...
Roche also said it will work to expand its menu of IVDR-compliant testing options to cover more than 60 analytes—including vitamin D metabolites, as well as immunosuppressant or other ...
Clue: It's more than just hangovers. It's not known as liquid courage for nothing. Dr. Remedios Majito-Francisco, MD, a general medicine specialist at the RHMF Medical Clinic, said drinking “lowers ...
Liquid AI Inc., an artificial intelligence startup and MIT spinoff developing generative AI models based on a fundamentally different architecture than transformer-based AI, today announced it has ...
(Reuters) - Generative artificial intelligence startup Liquid AI said on Friday that it had closed a $250 million early-stage funding round led by chipmaker Advanced Micro Devices, which is also ...
Michael D. Bartlett is in the Department of Mechanical Engineering, Soft Materials and Structures Lab and at the Macromolecules Innovation Institute, Virginia Tech, Blacksburg, Virginia 24061, USA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback